 | • レポートコード：MRC2304I0168 • 出版社/出版日：Persistence Market Research / 2023年1月26日 • レポート形態：英文、PDF、250ページ • 納品方法：Eメール • 産業分類：バイオ |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Site Licence | ￥1,140,000 (USD7,600) | ▷ お問い合わせ |
| Enterprisewide | ￥1,590,000 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Persistence Market Research社の本調査資料では、世界の融合生検市場について調査・分析を行い、市場の現状と今後の展望を整理しています。本書は、エグゼクティブサマリー、市場概要、市場リスク・動向分析、市場背景・基礎データポイント、主要成功要因、需要分析・予測、価値分析・予測、生検経路別（経会陰、経直腸）分析、エンドユーザー別（病院、診断センター、外来手術センター）分析、地域別（北米、中南米、ヨーロッパ、アジア太平洋、中東・アフリカ）分析、市場構造分析、競争分析、仮定、調査手法など、以下の構成で掲載しています。また、MedCom、ESAOTE SPA、KOELIS、Focal Healthcare、GeoScan Medical、UC-Care Medical Systems Ltd.などの企業情報が含まれています。 ・エグゼクティブサマリー ・市場概要 ・市場リスク・動向分析 ・市場背景・基礎データポイント ・主要成功要因 ・需要分析・予測 ・価値分析・予測 ・世界の融合生検市場規模：生検経路別 - 経会陰における市場規模 - 経直腸における市場規模 ・世界の融合生検市場規模：エンドユーザー別 - 病院における市場規模 - 診断センターにおける市場規模 - 外来手術センターにおける市場規模 ・世界の融合生検市場規模：地域別 - 北米の融合生検市場規模 - 中南米の融合生検市場規模 - ヨーロッパの融合生検市場規模 - アジア太平洋の融合生検市場規模 - 中東・アフリカの融合生検市場規模 ・市場構造分析 ・競争分析 ・仮定 ・調査手法 |
Fusion Biopsy Market- Scope of Report
A recent study by PMR on the Fusion Biopsy Market offers a 10-year forecast for 2023 to 2033. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with offering Fusion Biopsy.
The study also provides the dynamics responsible for influencing the future status of the Fusion Biopsy market over the forecast period. A detailed assessment of value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.
A list of prominent companies operating in the Fusion Biopsy market, along with their product portfolios, key strategies and SWOT analysis, enhances the reliability of this comprehensive research study.
Report Summary
The study offers comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales of Fusion Biopsy across the globe.
A comprehensive estimate on the market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of Fusion Biopsy during the forecast period. Price point comparison by region with global average price is also considered in the study.
Analysis on Market Size Evaluation
The market has been analyzed for each segment in terms of value (US$ Mn).
Estimates at global and regional levels for Fusion Biopsy and the Fusion Biopsy market are available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report. Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a service provider can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global Fusion Biopsy Market.
Inspected Assessment on Regional Segments
Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the Fusion Biopsy market during the forecast period.
Country-specific valuation on demand for Fusion Biopsy has been offered for each region, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.
Detailed breakup in terms of value & volume for emerging countries has also been included in the report.
In-depth Analysis on Competition
The report sheds light on leading players of Fusion Biopsy market along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in offering Fusion Biopsy has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.
Company profiles have been included in the report, which include essentials such as product portfolios and key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting the market status, and predicting the competition level in the Fusion Biopsy domain.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Persistence Market Research Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Fusion Biopsy Demand
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Mn)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background and Foundation Data Points
4.1. Global Fusion Biopsy Market (US$ Mn)
4.2. Fusion Biopsy Market Opportunity Assessment (US$ Mn)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors – Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Global Fusion Biopsy Market Growth
4.5.3. Fusion Biopsy Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Fusion Biopsy Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Fusion Biopsy Market Demand Analysis 2018-2022 and Forecast, 2023-2033
6.1. Historical Market Analysis, 2018-2022
6.2. Current and Future Market Projections, 2023-2033
6.3. Y-o-Y Growth Trend Analysis
7. Global Fusion Biopsy Market Value Analysis 2018-2022 and Forecast, 2023-2033
7.1. Historical Market Value (US$ Mn) Analysis, 2018-2022
7.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Fusion Biopsy Market Analysis 2018-2022 and Forecast 2023-2033, By Biopsy Route
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Biopsy Route Technique, 2018-2022
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Biopsy Route Technique, 2023-2033
8.3.1. Transperineal
8.3.2. Transrectal
8.4. Market Attractiveness Analysis By Biopsy Route Technique
9. Global Fusion Biopsy Market Analysis 2018-2022 and Forecast 2023-2033, By End-Use
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By End-Use, 2018-2022
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End-Use, 2023-2033
9.3.1. Hospitals
9.3.2. Diagnostic Centers
9.3.3. Ambulatory Surgery Centers
9.4. Market Attractiveness Analysis By End-Use
10. Global Fusion Biopsy Market Analysis 2018-2022 and Forecast 2023-2033, By Region
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Analysis By Region, 2018-2022
10.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2023-2033
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. Asia Pacific
10.3.5. Middle East and Africa (MEA)
10.4. Market Attractiveness Analysis By Region
11. North America Fusion Biopsy Market Analysis 2018-2022 and Forecast 2023-2033
11.1. Introduction
11.2. Pricing Analysis
11.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
11.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2023-2033
11.4.1. By Country
11.4.1.1. U.S.
11.4.1.2. Canada
11.4.1.3. Rest of North America
11.4.2. By Biopsy Route Technique
11.4.3. By End-Use
11.5. Market Attractiveness Analysis
11.5.1. By Country
11.5.2. By Biopsy Route Technique
11.5.3. By End-Use
12. Latin America Fusion Biopsy Market Analysis 2018-2022 and Forecast 2023-2033
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
12.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2023-2033
12.4.1. By Country
12.4.1.1. Brazil
12.4.1.2. Mexico
12.4.1.3. Rest of Latin America
12.4.2. By Biopsy Route Technique
12.4.3. By End-Use
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Biopsy Route Technique
12.5.3. By End-Use
13. Europe Fusion Biopsy Market Analysis 2018-2022 and Forecast 2023-2033
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2023-2033
13.4.1. By Country
13.4.1.1. Germany
13.4.1.2. France
13.4.1.3. U.K.
13.4.1.4. Italy
13.4.1.5. Benelux
13.4.1.6. Nordic Countries
13.4.1.7. Rest of Europe
13.4.2. By Biopsy Route Technique
13.4.3. By End-Use
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Biopsy Route Technique
13.5.3. By End-Use
14. Asia Pacific Fusion Biopsy Market Analysis 2018-2022 and Forecast 2023-2033
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2023-2033
14.4.1. By Country
14.4.1.1. China
14.4.1.2. Japan
14.4.1.3. South Korea
14.4.1.4. Rest of Asia Pacific
14.4.2. By Biopsy Route Technique
14.4.3. By End-Use
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Biopsy Route Technique
14.5.3. By End-Use
15. Middle East and Africa Fusion Biopsy Market Analysis 2018-2022 and Forecast 2023-2033
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2023-2033
15.4.1. By Country
15.4.1.1. GCC Countries
15.4.1.2. South Africa
15.4.1.3. Turkey
15.4.1.4. Rest of Middle East and Africa
15.4.2. By Biopsy Route Technique
15.4.3. By End-Use
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Biopsy Route Technique
15.5.3. By End-Use
16. Key Countries Fusion Biopsy Market Analysis 2018-2022 and Forecast 2023-2033
16.1. Introduction
16.1.1. Market Value Proportion Analysis, By Key Countries
16.1.2. Global Vs. Country Growth Comparison
16.2. US Fusion Biopsy Market Analysis
16.2.1. Value Proportion Analysis by Market Taxonomy
16.2.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
16.2.2.1. By Biopsy Route Technique
16.2.2.2. By End-Use
16.3. Canada Fusion Biopsy Market Analysis
16.3.1. Value Proportion Analysis by Market Taxonomy
16.3.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
16.3.2.1. By Biopsy Route Technique
16.3.2.2. By End-Use
16.4. Mexico Fusion Biopsy Market Analysis
16.4.1. Value Proportion Analysis by Market Taxonomy
16.4.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
16.4.2.1. By Biopsy Route Technique
16.4.2.2. By End-Use
16.5. Brazil Fusion Biopsy Market Analysis
16.5.1. Value Proportion Analysis by Market Taxonomy
16.5.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
16.5.2.1. By Biopsy Route Technique
16.5.2.2. By End-Use
16.6. Germany Fusion Biopsy Market Analysis
16.6.1. Value Proportion Analysis by Market Taxonomy
16.6.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
16.6.2.1. By Biopsy Route Technique
16.6.2.2. By End-Use
16.7. France Fusion Biopsy Market Analysis
16.7.1. Value Proportion Analysis by Market Taxonomy
16.7.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
16.7.2.1. By Biopsy Route Technique
16.7.2.2. By End-Use
16.8. Italy Fusion Biopsy Market Analysis
16.8.1. Value Proportion Analysis by Market Taxonomy
16.8.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
16.8.2.1. By Biopsy Route Technique
16.8.2.2. By End-Use
16.9. BENELUX Fusion Biopsy Market Analysis
16.9.1. Value Proportion Analysis by Market Taxonomy
16.9.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
16.9.2.1. By Biopsy Route Technique
16.9.2.2. By End-Use
16.10. UK Fusion Biopsy Market Analysis
16.10.1. Value Proportion Analysis by Market Taxonomy
16.10.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
16.10.2.1. By Biopsy Route Technique
16.10.2.2. By End-Use
16.11. Nordic Countries Fusion Biopsy Market Analysis
16.11.1. Value Proportion Analysis by Market Taxonomy
16.11.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
16.11.2.1. By Biopsy Route Technique
16.11.2.2. By End-Use
16.12. China Fusion Biopsy Market Analysis
16.12.1. Value Proportion Analysis by Market Taxonomy
16.12.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
16.12.2.1. By Biopsy Route Technique
16.12.2.2. By End-Use
16.13. Japan Fusion Biopsy Market Analysis
16.13.1. Value Proportion Analysis by Market Taxonomy
16.13.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
16.13.2.1. By Biopsy Route Technique
16.13.2.2. By End-Use
16.14. South Korea Fusion Biopsy Market Analysis
16.14.1. Value Proportion Analysis by Market Taxonomy
16.14.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
16.14.2.1. By Biopsy Route Technique
16.14.2.2. By End-Use
16.15. GCC Countries Fusion Biopsy Market Analysis
16.15.1. Value Proportion Analysis by Market Taxonomy
16.15.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
16.15.2.1. By Biopsy Route Technique
16.15.2.2. By End-Use
16.16. South Africa Fusion Biopsy Market Analysis
16.16.1. Value Proportion Analysis by Market Taxonomy
16.16.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
16.16.2.1. By Biopsy Route Technique
16.16.2.2. By End-Use
16.17. Turkey Fusion Biopsy Market Analysis
16.17.1. Value Proportion Analysis by Market Taxonomy
16.17.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
16.17.2.1. By Biopsy Route Technique
16.17.2.2. By End-Use
16.17.3. Competition Landscape and Player Concentration in the Country
17. Market Structure Analysis
17.1. Market Analysis by Tier of Companies
17.2. Market Concentration
17.3. Market Share Analysis of Top Players
17.4. Market Presence Analysis
17.4.1. By Regional footprint of Players
17.4.2. Product footprint by Players
18. Competition Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Competition Deep Dive
18.3.1. MedCom
18.3.1.1. Overview
18.3.1.2. Product Portfolio
18.3.1.3. Sales Footprint
18.3.1.4. Strategy Overview
18.3.2. ESAOTE SPA
18.3.2.1. Overview
18.3.2.2. Product Portfolio
18.3.2.3. Sales Footprint
18.3.2.4. Strategy Overview
18.3.3. KOELIS
18.3.3.1. Overview
18.3.3.2. Product Portfolio
18.3.3.3. Sales Footprint
18.3.3.4. Strategy Overview
18.3.4. Focal Healthcare
18.3.4.1. Overview
18.3.4.2. Product Portfolio
18.3.4.3. Sales Footprint
18.3.4.4. Strategy Overview
18.3.5. GeoScan Medical
18.3.5.1. Overview
18.3.5.2. Product Portfolio
18.3.5.3. Sales Footprint
18.3.5.4. Strategy Overview
18.3.6. UC-Care Medical Systems Ltd.
18.3.6.1. Overview
18.3.6.2. Product Portfolio
18.3.6.3. Sales Footprint
18.3.6.4. Strategy Overview
19. Assumptions and Acronyms Used
20. Research Methodology